Your browser doesn't support javascript.
loading
Enhanced CXCR4 Expression of Human CD8Low T Lymphocytes Is Driven by S1P4.
Burkard, Tobias; Dreis, Caroline; Herrero San Juan, Martina; Huhn, Meik; Weigert, Andreas; Pfeilschifter, Josef M; Radeke, Heinfried H.
Afiliación
  • Burkard T; pharmazentrum Frankfurt/ZAFES, Institute of Pharmacology and Toxicology, Hospital of the Goethe University, Frankfurt/Main, Germany.
  • Dreis C; pharmazentrum Frankfurt/ZAFES, Institute of Pharmacology and Toxicology, Hospital of the Goethe University, Frankfurt/Main, Germany.
  • Herrero San Juan M; pharmazentrum Frankfurt/ZAFES, Institute of Pharmacology and Toxicology, Hospital of the Goethe University, Frankfurt/Main, Germany.
  • Huhn M; pharmazentrum Frankfurt/ZAFES, Institute of Pharmacology and Toxicology, Hospital of the Goethe University, Frankfurt/Main, Germany.
  • Weigert A; Institute of Biochemistry I, Faculty of Medicine, Goethe-University, Frankfurt/Main, Germany.
  • Pfeilschifter JM; pharmazentrum Frankfurt/ZAFES, Institute of Pharmacology and Toxicology, Hospital of the Goethe University, Frankfurt/Main, Germany.
  • Radeke HH; pharmazentrum Frankfurt/ZAFES, Institute of Pharmacology and Toxicology, Hospital of the Goethe University, Frankfurt/Main, Germany.
Front Immunol ; 12: 668884, 2021.
Article en En | MEDLINE | ID: mdl-34504486

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos Infiltrantes de Tumor / Linfocitos T CD8-positivos / Receptores CXCR4 / Microambiente Tumoral / Receptores de Esfingosina-1-Fosfato Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos Infiltrantes de Tumor / Linfocitos T CD8-positivos / Receptores CXCR4 / Microambiente Tumoral / Receptores de Esfingosina-1-Fosfato Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article